Edward Weinstein

Edward Weinstein is the Director of Sigma Advanced Genetic Engineering, where he manages a state-of-the-art facility dedicated to creation of genetically engineered mouse, rat, and rabbit models designed for research use.  Prior to this position, Edward served as a Principal Scientist in the R&D division and Manager of Operations for Functional Genomics in the Research Biotechnology business unit of Sigma-Aldrich.  Before joining Sigma, he performed basic research within the pharmaceutical industry.  Edward had responsibility for the Molecular Profiling portfolio within Merck’s oncology franchise.  At Pfizer Edward worked on development of several therapeutic targets, creating mouse models for breast and colon carcinoma.  Edward received his Masters of Medical Science from Harvard Medical School and his Ph.D. in Genetics from Harvard University where his research focused on mouse models of mammary gland carcinoma.  Throughout his career Edward has focused on the application of animal models for the elucidation of mechanisms of complex disease processes.